BANK OF AMERICA CORP /DE/
BankPosition in ABOS — Acumen Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in ABOS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$755,709
+$248,990 QoQ
Shares Held
320,216
+33.3% QoQ
Ownership
0.443%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 84 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 50.43970320033977.ToString("F0")%
Shared 0.ToString("F0")%
None 49.56029679966023.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. ABOS ranks #222 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ABOS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $755,709 | 320,216 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $506,719 | 240,152 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $365,475 | 213,729 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $170,529 | 147,009 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $174,826 | 158,934 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $255,707 | 148,668 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $344,034 | 138,724 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $296,993 | 122,725 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $326,493 | 80,616 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $400,775 | 104,369 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $68,370 | 16,475 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $75,722 | 15,743 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $113,049 | 27,845 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $208,514 | 38,614 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $226,406 | 22,573 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $132,191 | 28,126 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $101,874 | 26,055 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $142,601 | 21,095 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $14,710 | 990 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||